Freehand CEO Debuted AI Teams at LogiPharma USA

Nitin Jayakrishnan presented autonomous AI technology for pharmaceutical supply chain management in Boston.

Updated on Oct. 6, 2026 in Artificial Intelligence

Isometric editorial illustration showing a complex modular network of interconnected logistical nodes and geometric pipelines, representing pharmaceutical supply chain AI technology.
Freehand CEO Nitin Jayakrishnan introduced an autonomous AI platform at LogiPharma USA 2026 to help pharmaceutical firms manage complex supply chain billing and procurement. AI Illustration. Upload story photo >

Live Poll

Do you trust that AI automation improves the reliability of corporate supply chains?

Freehand CEO Nitin Jayakrishnan showcased the company's AI Teams technology during a keynote panel at the LogiPharma USA 2026 conference in Boston. The platform aims to assist pharmaceutical firms in managing complex supply chain operations through autonomous systems.

Why it matters

Pharmaceutical supply chains face significant global volatility, driving a demand for increased operational control. Freehand's AI seeks to address this by automating procurement and accounts payable tasks to improve efficiency.

Freehand uses proprietary Context Graphs to link enterprise systems, contracts, and documents. This allows their AI Teams to autonomously investigate payment disputes and execute complex financial transactions.

The players

Nitin Jayakrishnan

He serves as the CEO and co-founder of the AI firm Freehand.

Freehand

This company provides AI services for procurement and accounts payable and counts major corporations like Meta and Johnson & Johnson among its customers.

LogiPharma USA

This is a major annual industry conference focused on pharmaceutical supply chain and logistics innovation.

The details

The technology is designed to integrate across disparate enterprise systems to provide automated oversight of accounts payable operations. By utilizing these Context Graphs, the system can execute tasks such as coding transactions and investigating billing discrepancies without human intervention.

Timeline

  1. July 2026: Freehand successfully secured $75 million in new capital.

  2. October 5-7, 2026: The LogiPharma USA 2026 conference was held in Boston.

  3. October 6, 2026: CEO Nitin Jayakrishnan delivered the keynote panel presentation.

The Tech Race

The push for autonomous supply chain management reflects a broader transition toward AI-driven enterprise resource planning. This technology replaces legacy manual verification processes to position Freehand against traditional software providers in the logistics sector.

For businesses adopting these tools, the technology promises to reduce administrative bottlenecks and speed up payment cycles. Users should anticipate shifts in how procurement departments manage dispute resolution and transaction coding workflows.

The takeaway

Autonomous AI agents are increasingly moving from experimental prototypes to practical enterprise applications within the pharmaceutical industry. Firms looking to adopt these systems should prioritize evaluating how well AI tools integrate with their specific legacy procurement software.

What happens next

Freehand will continue demonstrating its AI Teams technology at booth #426 at the LogiPharma USA 2026 conference through October 7, 2026.

Further reading

Learn more about the latest innovations in Artificial Intelligence impacting the modern enterprise landscape.

More information

For more details on the firm and its products, visit the Freehand company information website.

Live Poll

Do you trust that AI automation improves the reliability of corporate supply chains?